Head of Biotherapeutics and Staff Scientist @ (June 2022 - November 2023)
Sr. Director of Protein Sciences and Staff Scientist @ (December 2021 - June 2022)
Senior Principal Scientist and Project Team Leader @ (November 2018 - December 2021)
Director, Structural Biology @ (November 2016 - March 2020)
Senior Scientist and Project Team Leader @ (September 2012 - November 2018)
Scientist @ (January 2009 - September 2012)
Research Scientist II @ (August 2005 - December 2008)
Membrane Protein Structural Genomics Group Leader @ (December 2003 - August 2005)
Postdoctoral Fellow @ (February 2002 - December 2003)
Christopher Koth Education
University of Toronto
PhD (Structural and Molecular Biology)
1996-2002
Christopher Koth Skills
High Throughput Screening
Protein Purification
Drug Discovery
Structural Biology
Biochemistry
Purification
Protein Chemistry
Cell Culture
Protein Expression
Ion Channels
GPCRs
Protein Structure
Molecular Biology
Assay Development
Western Blotting
Characterization
Membrane Proteins
Fluorescence
Kinases
HPLC
SDS-PAGE
Customer Service
Sds Page
Data Analysis
Microsoft Excel
Marketing
Microsoft Office
High Throughput
Christopher Koth Summary
Christopher Koth, based in South San Francisco, CA, US, is currently a Senior Vice President, Biotherapeutics at Denali Therapeutics. Christopher Koth brings experience from previous roles at Denali Therapeutics and Genentech. Christopher Koth holds a 1996 - 2002 PhD in Structural and Molecular Biology @ University of Toronto. With a robust skill set that includes High Throughput Screening, Protein Purification, Drug Discovery, Structural Biology, Biochemistry and more. Christopher Koth has 2 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Christopher Koth?
Find contact details for 700 million professionals.